Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 05, 2026

SELL
$4.58 - $5.96 $21,246 - $27,648
-4,639 Closed
0 $0
Q3 2024

Jan 05, 2026

BUY
$4.26 - $6.0 $5,827 - $8,208
1,368 Added 41.82%
4,639 $22.6 Million
Q2 2024

Jan 05, 2026

BUY
$3.99 - $6.04 $13,051 - $19,756
3,271 New
3,271 $16.7 Million
Q4 2023

Jan 05, 2026

SELL
$4.35 - $6.88 $896 - $1,417
-206 Reduced 6.68%
2,880 $18.5 Million
Q3 2023

Jan 05, 2026

BUY
$4.52 - $8.9 $4,298 - $8,463
951 Added 44.54%
3,086 $13.9 Million
Q2 2023

Jan 05, 2026

BUY
$4.79 - $8.3 $646 - $1,120
135 Added 6.75%
2,135 $12.6 Million
Q1 2023

Jan 05, 2026

BUY
$5.3 - $10.93 $10,600 - $21,860
2,000 New
2,000 $10.6 Million

Others Institutions Holding EXAI

About Exscientia plc


  • Ticker EXAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,461,000
  • Market Cap $593M
  • Description
  • Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...
More about EXAI
Track This Portfolio

Track Chesapeake Asset Management LLC Portfolio

Follow Chesapeake Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesapeake Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chesapeake Asset Management LLC with notifications on news.